BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8742546)

  • 1. Serotonin reuptake inhibitor-related extrapyramidal side effects in two patients with cerebral palsy.
    Rone LA; Ferrando SJ
    Psychosomatics; 1996; 37(2):165-6. PubMed ID: 8742546
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of SSRI response.
    Salzman C
    Harv Rev Psychiatry; 1996; 4(4):215-7. PubMed ID: 9384996
    [No Abstract]   [Full Text] [Related]  

  • 3. Remission of SSRI-induced akathisia after switch to nefazodone.
    Chelben J; Strous RD; Lustig M; Baruch Y
    J Clin Psychiatry; 2001 Jul; 62(7):570-1. PubMed ID: 11488371
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of personality by serotonergic intervention.
    Balon R
    Am J Psychiatry; 1999 Jun; 156(6):985. PubMed ID: 10360169
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
    Fava M; Judge R; Hoog SL; Nilsson ME; Koke SC
    J Clin Psychiatry; 2000 Nov; 61(11):863-7. PubMed ID: 11105740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapyramidal symptoms with selective serotonin reuptake inhibitors.
    Arya DK
    Br J Psychiatry; 1994 Dec; 165(6):728-33. PubMed ID: 7881774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
    Garland EJ; Baerg EA
    J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
    Judge R; Parry MG; Quail D; Jacobson JG
    Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study.
    Henry ME; Moore CM; Kaufman MJ; Michelson D; Schmidt ME; Stoddard E; Vuckevic AJ; Berreira PJ; Cohen BM; Renshaw PF
    Am J Psychiatry; 2000 Sep; 157(9):1506-8. PubMed ID: 10964871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression: making the diagnosis and using SSRIs in the older patient.
    Reynolds CF
    Geriatrics; 1996 Oct; 51(10):28-34. PubMed ID: 8863755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agomelatine: new drug. Adverse effects and no proven efficacy.
    Prescrire Int; 2009 Dec; 18(104):241-5. PubMed ID: 20020562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
    Sheffield RE; Lo Sasso AT; Young CH; Way K
    Adm Policy Ment Health; 2002 Nov; 30(2):121-39. PubMed ID: 12680617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of serotonin re-uptake inhibitors with perhexiline.
    Alderman CP; Hundertmark JD; Soetratma TW
    Aust N Z J Psychiatry; 1997 Aug; 31(4):601-3. PubMed ID: 9272272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients].
    Montejo AI; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Daniel E; de Dios A; de la Gándara J; Derecho J; Franco M; Gómez MJ; Macías JA; Martín T; Pérez V; Sánchez JM; Sánchez S; Vicens E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):311-21. PubMed ID: 9054202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients.
    Gülseren L; Gülseren S; Hekimsoy Z; Mete L
    Arch Med Res; 2005; 36(2):159-65. PubMed ID: 15847950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unfortunate title?].
    Waern M; Agren H; Hägglöf B; Lundin B
    Lakartidningen; 2004 Jun; 101(26-27):2292. PubMed ID: 15281636
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
    Ahrold TK; Meston CM
    J Sex Marital Ther; 2009; 35(4):311-9. PubMed ID: 19466669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.